Are trial participants adequately safeguarded by the ethics committees - the Indian scenario?
Saved in:
Main Authors: | Karan eThakkar (Author), Dr Gauri eBilla (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2014-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Light at the end of the tunnel ? : The Great Indian Pharmacoeconomics story.
by: Karan eThakkar, et al.
Published: (2013) -
The concept of: Generic drugs and patented drugs Vs brand name drugs and non-proprietary (generic) name drugs.
by: Karan eThakkar, et al.
Published: (2013) -
The role of ethics committee in confirmation bias mitigation in dental research: Indian perspective
by: Thorakkal Shamim
Published: (2017) -
Lymphadenopathy: Differentiation between Tuberculosis and other non-tuberculosis causes like Follicular Lymphoma.
by: Karan eThakkar, et al.
Published: (2016) -
Evolution of ethics in clinical research and ethics committee
by: Nilay Kanti Das, et al.
Published: (2017)